Related Experiment Video
Updated: May 27, 2026

06:45
Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
Getting it right first time in a patient with Candida peritonitis
1Department of Intensive Care, University Medical Center, Utrecht, The Netherlands. D.W.deLange@umcutrecht.nl
Mycoses
|December 1, 2011
Summary
This case report details a patient with mediastinitis, pleural empyema, and peritonitis caused by Candida glabrata and Enterococcus faecium following complex surgery. It discusses treatment challenges for healthcare-associated invasive Candida infections in critically ill patients.
Area of Science:
- Medicine
- Infectious Diseases
- Surgical Critical Care
Background:
- Robot-assisted thoracolaparoscopic esophagectomy is a complex procedure with potential complications.
- Healthcare-associated invasive fungal infections, particularly Candida, pose significant challenges in critically ill patients.
- The emergence of multidrug-resistant organisms necessitates careful consideration of treatment strategies.
Observation:
- A patient developed mediastinitis, pleural empyema, and peritonitis after a complicated robot-assisted thoracolaparoscopic esophagectomy.
- The infections were caused by a polymicrobial etiology, including Candida glabrata and Enterococcus faecium.
- The patient's critical condition presented therapeutic dilemmas for management.
Findings:
- Treatment of invasive Candida glabrata infections, especially in polymicrobial settings, can be challenging.
- Echinocandin therapy is a common treatment for invasive candidiasis, but resistance or suboptimal response can occur.
- This case highlights the complexities in managing invasive fungal infections in the context of surgical complications.
Implications:
- Physicians must be vigilant for invasive Candida infections in critically ill surgical patients.
- Current guidelines for treating healthcare-associated invasive Candida infections may require adaptation for complex cases.
- Further research into optimal therapeutic approaches for invasive Candida glabrata and polymicrobial infections is warranted.